Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
Sweden: Police Suspect Grenade Used in Recent Attack
Previously Deported Illegal Goes On Murderous Rampage Days After CT Gov Refused To Work With ICE
Report: Kushner, Ivanka Stripped Anti-Climate Change Executive Order, Plot To Push Global Warming
Sweden's Migrant Crime Wave Becomes Top National Story As Media's Lies Backfire
'Trump Was Right': Migrants Riot, Loot, Fight With Police And Set Cars On Fire In Sweden
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.